Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Depression (Adult and Geriatric)
Location: United States, IL
A study to evaluate the efficacy, safety and tolerability of a serotonin and norepinephrine reuptake inhibitor compared to a placebo in patients with depression.
This study will evaluate the efficacy, safety and tolerability of a serotonin and norepinephrine reuptake inhibitor compared to a placebo in patients with depression. Your participation is expected to last up to 11 weeks and will require 8 visits to the site. During the study, you will be assigned, by chance (like flipping a coin), to a treatment with either F2695 (active drug) or placebo (an inactive substance). You will have a 1 in 2 (or 50%) chance of receiving placebo. The dose may be increased at certain visits during the study based on your response and tolerability and the study doctor's medical opinion. This is a double-blind study which means neither you nor the study doctor will know which study treatment you have been assigned. However, this information is available to the study doctor in the case of an emergency.
You will not be eligible to participate in this study if you need to take any medications, vitamins, supplements or herbal preparations that are not allowed while you are in the study. The study doctor will go over the list of over-the-counter medications, prescription medications and herbal preparations that you are not allowed to take while participating in this study. You will not be eligible to participate if you are a female who is pregnant, planning to become pregnant or is breastfeeding. You cannot participate if you are a female of childbearing potential and not using a medically acceptable method of birth control. You will not be eligible if you have a history of epilepsy or a history of narrow angle glaucoma.
Chicago Research Center, Inc
3401 N Central Avenue
Chicago, IL 60634
Research Center Information: Chicago Research Center, Inc
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these